The pharmaceutical industry is developing newer and potentially cheaper or more effective molecules that target GLP-1 and associated pathways (for example, the so-called dual- and triple-agonists tirzepatide, retatutride and orfoglipon) 257,258
A physician consultation is required to determine if this combination aligns with your health profile and goals
Low glutathione levels have been linked to an increased risk of arthritis, cancer, cardiovascular disease, diabetes, gut issues, and more, so this isnt something you should ignore
Even if you are not sick, Glutathione is good for you
For Wegovy specifically, patients who cannot tolerate the 2.4 mg dose may use 1.7 mg as a maintenance dose
Further, while essentially all SGLT2 inhibitors have been shown to produce very similar effects on HF, progression of CKD, reduction in HbA1c and weight loss, there are major differences between the effect of different GLP-1 receptor agonists on all of these parameters